In Vitro Diagnostics
In Vitro Diagnostics (IVD) has been substantially disrupted by the rise of high technology supply chains in Asia and the proliferation of highly specialized start-up biotechnology competitors who have increasingly snatched market share from traditional market leaders.
Accordingly, Virax is positioned in high-growth Molecular Diagnosis & Flow Cytometry IVD segments seeing the fastest levels of year-on-year development in our sector. Furthermore, our Asia-centric supply chain offers unparalleled cost savings compared to more developed competitors who rely more on antiquated and high-priced supply chains.
Virax is committed to providing best in-class IVD and immunological testing in the laboratory and at Point-of-Care.
We are at the forefront of innovation in point-of-care biomarker testing, bringing new test methodologies and devices that can produce highly accurate, lab-quality results at the bedside or in the home in minutes.